CD-NP is a novel rationally designed chimeric natriuretic peptide in clinical studies for an initial indication of acute decompensated heart failure. » More
February 4, 2010 - Nile Therapeutics to Present at BIO CEO and Investor Conference » Read
Event:
Nile Therapeutics Q4 Earnings Call
Date:
Tuesday, March 10, 2009
Time:
4:30 PM ET
Webcast:
Interested investors or potential investors may conveniently receive E-mail alert messages whenever certain new company
information is posted to this site. To automatically receive Nile Therapeutics, Inc. e-mail alerts, enter your e-mail address and click on the Subscribe button.
